Metabolic effects of  -guanidinobutyramide. I. In vivo study in anesthetized dogs.
D000577:Amides; D000771:Anesthesia, Intravenous; D000818:Animals; D000941:Antigens; D001786:Blood Glucose / Q000032:analysis / Q000378:metabolism*; D001794:Blood Pressure / Q000187:drug effects; D001806:Blood Urea Nitrogen; D002087:Butyrates; D002247:Carbon Isotopes; D002395:Catecholamines / Q000097:blood; D004285:Dogs; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006146:Guanidines; D006400:Hematocrit; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D007003:Hypoglycemia / Q000097:blood / Q000139:chemically induced* / Q000378:metabolism / Q000652:urine; D007328:Insulin / Q000097:blood / Q000378:metabolism; D000078790:Insulin Secretion; D007700:Kinetics; D008099:Liver / Q000378:metabolism; D010646:Phentolamine / Q000494:pharmacology
D000577:Amides; D000941:Antigens; D001786:Blood Glucose; D002087:Butyrates; D002247:Carbon Isotopes; D002395:Catecholamines; D005230:Fatty Acids, Nonesterified; D006146:Guanidines; D007328:Insulin; D006897:Hydroxyindoleacetic Acid; D010646:Phentolamine